Enhanced expression of mitochondrial superoxide dismutase leads to prolonged in vivo cell cycle progression and up-regulation of mitochondrial thioredoxin

Free Radical Biology and Medicine

Volumn 48, Issue 11, 2010, Pages 1501-1512

  Kim, Aekyong ^a,e   Joseph, Suman ^b   Khan, Aslam ^a   Epstein, Charles J ^b   Sobel, Raymond ^c,d   Huang, Ting Ting ^a,d  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^e Catholic University of Daegu   (South Korea)

Author keywords

Cell cycle progression; Free radicals; Liver regeneration; Mitochondria; MnSOD; Partial hepatectomy; Thioredoxin 2

Indexed keywords

BROXURIDINE; CYCLINE; MANGANESE SUPEROXIDE DISMUTASE; PEROXIDASE; THIOREDOXIN; THIOREDOXIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROBLAST; IN VIVO STUDY; LIVER REGENERATION; MITOCHONDRION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION STATE; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE REGENERATION; TRANSGENIC MOUSE; UPREGULATION;

ACONITATE HYDRATASE; ANIMALS; ANTIOXIDANTS; CELL CYCLE; FEMALE; LIVER REGENERATION; MALE; MICE; MICE, TRANSGENIC; MITOCHONDRIA; PROLIFERATING CELL NUCLEAR ANTIGEN; SEX FACTORS; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE; THIOREDOXINS; TYROSINE; UP-REGULATION;

MUS; MUS MUSCULUS;

EID: 77952548498     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2010.02.028     Document Type: Article

References (82)

1. Li Y., Huang T.T., Carlson E.J., Melov S., Ursell P.C., Olson J.L., Noble L.J., Yoshimura M.P., Berger C., Chan P.H., Wallace D.C., Epstein C.J. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat. Genet. 1995, 11:376-381.
2. Chen Z., Siu B., Ho Y.S., Vincent R., Chua C.C., Hamdy R.C., Chua B.H. Overexpression of MnSOD protects against myocardial ischemia/reperfusion injury in transgenic mice. J. Mol. Cell. Cardiol. 1998, 30:2281-2289.
3. Klivenyi P., St Clair D., Wermer M., Yen H.C., Oberley T., Yang L., Flint Beal M. Manganese superoxide dismutase overexpression attenuates MPTP toxicity. Neurobiol. Dis. 1998, 5:253-258.
4. Yen H.C., Oberley T.D., Gairola C.G., Szweda L.I., St Clair D.K. Manganese superoxide dismutase protects mitochondrial complex I against adriamycin-induced cardiomyopathy in transgenic mice. Arch. Biochem. Biophys. 1999, 362:59-66.
5. Epperly M.W., Kagan V.E., Sikora C.A., Gretton J.E., Defilippi S.J., Bar-Sagi D., Greenberger J.S. Manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) administration protects mice from esophagitis associated with fractionated radiation. Int. J. Cancer 2001, 96:221-231.
6. Carpenter M., Epperly M.W., Agarwal A., Nie S., Hricisak L., Niu Y., Greenberger J.S. Inhalation delivery of manganese superoxide dismutase-plasmid/liposomes protects the murine lung from irradiation damage. Gene Ther. 2005, 12:685-693.
7. Zhang X., Epperly M.W., Kay M.A., Chen Z.Y., Dixon T., Franicola D., Greenberger B.A., Komanduri P., Greenberger J.S. Radioprotection in vitro and in vivo by minicircle plasmid carrying the human manganese superoxide dismutase transgene. Hum. Gene Ther. 2008, 19:820-826.
8. Sun J., Folk D., Bradley T.J., Tower J. Induced overexpression of mitochondrial Mn-superoxide dismutase extends the life span of adult Drosophila melanogaster. Genetics 2002, 161:661-672.
9. Sun J., Molitor J., Tower J. Effects of simultaneous over-expression of Cu/ZnSOD and MnSOD on Drosophila melanogaster life span. Mech. Ageing Dev. 2004, 125:341-349.
10. Harris N., Costa V., MacLean M., Mollapour M., Moradas-Ferreira P., Piper P.W. MnSOD overexpression extends the yeast chronological (G(0)) life span but acts independent of Sir2p histone deacetylase to shorten the replicative life span of dividing cells. Free Radic. Biol. Med. 2003, 34:1599-1606.
11. Perez V.I., Van Remmen H., Bokov A., Epstein C.J., Vijg J., Richardson A. The overexpression of major antioxidant enzymes does not extend the lifespan of mice. Aging Cell 2009, 8:73-75.
12. Dionisi O., Galeotti T., Terranova T., Azzi A. Superoxide radicals and hydrogen peroxide formation in mitochondria from normal and neoplastic tissues. Biochim. Biophys. Acta 1975, 403:292-300.
13. Sahu S.K., Oberley L.W., Stevens R.H., Riley E.F. Superoxide dismutase activity of Ehrlich ascites tumor cells. J. Natl. Cancer Inst. 1977, 58:1125-1128.
14. Oberley L.W., Buettner G.R. Role of superoxide dismutase in cancer: a review. Cancer Res. 1979, 39:1141-1149.
15. Oberley L.W. Mechanism of the tumor suppressive effect of MnSOD overexpression. Biomed. Pharmacother. 2005, 59:143-148.
16. Zhao Y., Xue Y., Oberley T.D., Kiningham K.K., Lin S.M., Yen H.C., Majima H., Hines J., St Clair D. Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model. Cancer Res. 2001, 61:6082-6088.
17. Zhao Y., Oberley T.D., Chaiswing L., Lin S.M., Epstein C.J., Huang T.T. St Clair, D. Manganese superoxide dismutase deficiency enhances cell turnover via tumor promoter-induced alterations in AP-1 and p53-mediated pathways in a skin cancer model. Oncogene 2002, 21:3836-3846.
18. van de Wetering C.I., Coleman M.C., Spitz D.R., Smith B.J., Knudson C.M. Manganese superoxide dismutase gene dosage affects chromosomal instability and tumor onset in a mouse model of T cell lymphoma. Free Radic. Biol. Med. 2008, 44:1677-1686.
19. Zhao Y., Chaiswing L., Oberley T.D., Batinic-Haberle I., St Clair W., Epstein C.J., St Clair D. A mechanism-based antioxidant approach for the reduction of skin carcinogenesis. Cancer Res. 2005, 65:1401-1405.
20. Van Remmen H., Ikeno Y., Hamilton M., Pahlavani M., Wolf N., Thorpe S.R., Alderson N.L., Baynes J.W., Epstein C.J., Huang T.T., Nelson J., Strong R., Richardson A. Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol. Genomics 2003, 16:29-37.
21. Weydert C., Roling B., Liu J., Hinkhouse M.M., Ritchie J.M., Oberley L.W., Cullen J.J. Suppression of the malignant phenotype in human pancreatic cancer cells by the overexpression of manganese superoxide dismutase. Mol. Cancer Ther. 2003, 2:361-369.
22. Venkataraman S., Jiang X., Weydert C., Zhang Y., Zhang H.J., Goswami P.C., Ritchie J.M., Oberley L.W., Buettner G.R. Manganese superoxide dismutase overexpression inhibits the growth of androgen-independent prostate cancer cells. Oncogene 2005, 24:77-89.
23. Weydert C.J., Waugh T.A., Ritchie J.M., Iyer K.S., Smith J.L., Li L., Spitz D.R., Oberley L.W. Overexpression of manganese or copper-zinc superoxide dismutase inhibits breast cancer growth. Free Radic. Biol. Med. 2006, 41:226-237.
24. Weydert C.J., Zhang Y., Sun W., Waugh T.A., Teoh M.L., Andringa K.K., Aykin-Burns N., Spitz D.R., Smith B.J., Oberley L.W. Increased oxidative stress created by adenoviral MnSOD or CuZnSOD plus BCNU (1, 3-bis(2-chloroethyl)-1-nitrosourea) inhibits breast cancer cell growth. Free Radic. Biol. Med. 2008, 44:856-867.
25. Ridnour L.A., Oberley T.D., Oberley L.W. Tumor suppressive effects of MnSOD overexpression may involve imbalance in peroxide generation versus peroxide removal. Antioxid. Redox Signal. 2004, 6:501-512.
26. Kim A., Zhong W., Oberley T.D. Reversible modulation of cell cycle kinetics in NIH/3T3 mouse fibroblasts by inducible overexpression of mitochondrial manganese superoxide dismutase. Antioxid. Redox Signal. 2004, 6:489-500.
27. Zhang H.J., Yan T., Oberley T.D., Oberley L.W. Comparison of effects of two polymorphic variants of manganese superoxide dismutase on human breast MCF-7 cancer cell phenotype. Cancer Res. 1999, 59:6276-6283.
28. Li N., Oberley T.D., Oberley L.W., Zhong W. Inhibition of cell growth in NIH/3T3 fibroblasts by overexpression of manganese superoxide dismutase: mechanistic studies. J. Cell. Physiol. 1998, 175:359-369.
29. Li N., Oberley T.D. Modulation of antioxidant enzymes, reactive oxygen species, and glutathione levels in manganese superoxide dismutase-overexpressing NIH/3T3 fibroblasts during the cell cycle. J. Cell. Physiol. 1998, 177:148-160.
30. Oberley T.D., Schultz J.L., Li N., Oberley L.W. Antioxidant enzyme levels as a function of growth state in cell culture. Free Radic. Biol. Med. 1995, 19:53-65.
31. Erlejman A.G., Oteiza P.I. The oxidant defense system in human neuroblastoma IMR-32 cells predifferentiation and postdifferentiation to neuronal phenotypes. Neurochem. Res. 2002, 27:1499-1506.
32. Sarsour E.H., Venkataraman S., Kalen A.L., Oberley L.W., Goswami P.C. Manganese superoxide dismutase activity regulates transitions between quiescent and proliferative growth. Aging Cell 2008, 7:405-417.
33. Raineri I., Carlson E.J., Gacayan R., Carra S., Oberley T.D., Huang T.T., Epstein C.J. Strain-dependent high-level expression of a transgene for manganese superoxide dismutase is associated with growth retardation and decreased fertility. Free Radic. Biol. Med. 2001, 31:1018-1030.
34. Mansuy I.M., Winder D.G., Moallem T.M., Osman M., Mayford M., Hawkins R.D., Kandel E.R. Inducible and reversible gene expression with the rtTA system for the study of memory. Neuron 1998, 21:257-265.
35. Kistner A., Gossen M., Zimmermann F., Jerecic J., Ullmer C., Lubbert H., Bujard H. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:10933-10938.
36. Huang T.T., Raineri I., Eggerding F., Epstein C.J. Transgenic and mutant mice for oxygen free radical studies. Methods Enzymol. 2002, 349:191-213.
37. Hebert P.D., Beaton M.J. Methodologies for Allozyme Analysis Using Cellulose Acetate Electrophoresis-A Practical Handbook 1989, Helena Laboratories, Beaumont, TX.
38. Carlberg I., Mannervik B. Glutathione reductase. Methods Enzymol. 1985, 113:484-490.
39. Pabst M.J., Habig W.H., Jakoby W.B. Glutathione S-transferase A: a novel kinetic mechanism in which the major reaction pathway depends on substrate concentration. J. Biol. Chem. 1974, 249:7140-7147.
40. Greene A.K., Puder M. Partial hepatectomy in the mouse: technique and perioperative management. J. Invest. Surg. 2003, 16:99-102.
41. Weglarz T.C., Sandgren E.P. Timing of hepatocyte entry into DNA synthesis after partial hepatectomy is cell autonomous. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:12595-12600.
42. DeAngelis R.A., Markiewski M.M., Taub R., Lambris J.D. A high-fat diet impairs liver regeneration in C57BL/6 mice through overexpression of the NF-kappaB inhibitor, IkappaBalpha. Hepatology 2005, 42:1148-1157.
43. Ho Y.S., Vincent R., Dey M.S., Slot J.W., Crapo J.D. Transgenic models for the study of lung antioxidant defense: enhanced manganese-containing superoxide dismutase activity gives partial protection to B6C3 hybrid mice exposed to hyperoxia. Am. J. Respir. Cell Mol. Biol. 1998, 18:538-547.
44. Epperly M.W., Travis E.L., Whitsett J.A., Raineri I., Epstein C.J., Greenberger J.S. Overexpression of manganese superoxide dismutase (MnSOD) in whole lung or alveolar type II cells of MnSOD transgenic mice does not provide intrinsic lung irradiation protection. Int. J. Cancer 2001, 96:11-21.
45. Chen H., Li X., Epstein P.N. MnSOD and catalase transgenes demonstrate that protection of islets from oxidative stress does not alter cytokine toxicity. Diabetes 2005, 54:1437-1446.
46. Shen X., Zheng S., Metreveli N.S., Epstein P.N. Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy. Diabetes 2006, 55:798-805.
47. Goto H., Nishikawa T., Sonoda K., Kondo T., Kukidome D., Fujisawa K., Yamashiro T., Motoshima H., Matsumura T., Tsuruzoe K., Araki E. Endothelial MnSOD overexpression prevents retinal VEGF expression in diabetic mice. Biochem. Biophys. Res. Commun. 2008, 366:814-820.
48. 2. Free Radic. Biol. Med. 2000, 29:801-813.
49. Ough M., Lewis A., Zhang Y., Hinkhouse M.M., Ritchie J.M., Oberley L.W., Cullen J.J. Inhibition of cell growth by overexpression of manganese superoxide dismutase (MnSOD) in human pancreatic carcinoma. Free Radic. Res. 2004, 38:1223-1233.
50. 2 in cells and thereby their biological state. Free Radic. Biol. Med. 2006, 41:1338-1350.
51. Kim A., Murphy M.P., Oberley T.D. Mitochondrial redox state regulates transcription of the nuclear-encoded mitochondrial protein manganese superoxide dismutase: a proposed adaptive response to mitochondrial redox imbalance. Free Radic. Biol. Med. 2005, 38:644-654.
52. Ahsan M.K., Lekli I., Ray D., Yodoi J., Das D.K. Redox regulation of cell survival by the thioredoxin superfamily: an implication of redox gene therapy in the heart. Antioxid. Redox Signal. 2009, 11:2741-2758.
53. Nonn L., Williams R.R., Erickson R.P., Powis G. The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous mice. Mol. Cell. Biol. 2003, 23:916-922.
54. Tanaka T., Hosoi F., Yamaguchi-Iwai Y., Nakamura H., Masutani H., Ueda S., Nishiyama A., Takeda S., Wada H., Spyrou G., Yodoi J. Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependent apoptosis. EMBO J. 2002, 21:1695-1703.
55. Perez V.I., Lew C.M., Cortez L.A., Webb C.R., Rodriguez M., Liu Y., Qi W., Li Y., Chaudhuri A., Van Remmen H., Richardson A., Ikeno Y. Thioredoxin 2 haploinsufficiency in mice results in impaired mitochondrial function and increased oxidative stress. Free Radic. Biol. Med. 2008, 44:882-892.
56. Chen Y., Cai J., Murphy T.J., Jones D.P. Overexpressed human mitochondrial thioredoxin confers resistance to oxidant-induced apoptosis in human osteosarcoma cells. J. Biol. Chem. 2002, 277:33242-33248.
57. Chen Y., Cai J., Jones D.P. Mitochondrial thioredoxin in regulation of oxidant-induced cell death. FEBS Lett. 2006, 580:6596-6602.
58. Chen Y., Yu M., Jones D.P., Greenamyre J.T., Cai J. Protection against oxidant-induced apoptosis by mitochondrial thioredoxin in SH-SY5Y neuroblastoma cells. Toxicol. Appl. Pharmacol. 2006, 216:256-262.
59. Chen Y., Go Y.M., Pohl J., Reed M., Cai J., Jones D.P. Increased mitochondrial thioredoxin 2 potentiates N-ethylmaleimide-induced cytotoxicity. Chem. Res. Toxicol. 2008, 21:1205-1210.
60. Dai S., He Y., Zhang H., Yu L., Wan T., Xu Z., Jones D., Chen H., Min W. Endothelial-specific expression of mitochondrial thioredoxin promotes ischemia-mediated arteriogenesis and angiogenesis. Arterioscler. Thromb. Vasc. Biol. 2009, 29:495-502.
61. Widder J.D., Fraccarollo D., Galuppo P., Hansen J.M., Jones D.P., Ertl G., Bauersachs J. Attenuation of angiotensin II-induced vascular dysfunction and hypertension by overexpression of thioredoxin 2. Hypertension 2009, 54:338-344.
62. Damdimopoulos A.E., Miranda-Vizuete A., Pelto-Huikko M., Gustafsson J.A., Spyrou G. Human mitochondrial thioredoxin: involvement in mitochondrial membrane potential and cell death. J. Biol. Chem. 2002, 277:33249-33257.
63. Jurado J., Prieto-Alamo M.J., Madrid-Risquez J., Pueyo C. Absolute gene expression patterns of thioredoxin and glutaredoxin redox systems in mouse. J. Biol. Chem. 2003, 278:45546-45554.
64. Rohrbach S., Gruenler S., Teschner M., Holtz J. The thioredoxin system in aging muscle: key role of mitochondrial thioredoxin reductase in the protective effects of caloric restriction?. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 291:R927-935.
65. De Zoysa M., Pushpamali W.A., Whang I., Kim S.J., Lee J. Mitochondrial thioredoxin-2 from disk abalone (Haliotis discus discus): molecular characterization, tissue expression and DNA protection activity of its recombinant protein. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 2008, 149:630-639.
66. Gardner P.R., Fridovich I. Inactivation-reactivation of aconitase in Escherichia coli: a sensitive measure of superoxide radical. J. Biol. Chem. 1992, 267:8757-8763.
67. Hausladen A., Fridovich I. Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not. J. Biol. Chem. 1994, 269:29405-29408.
68. Hausladen A., Fridovich I. Measuring nitric oxide and superoxide: rate constants for aconitase reactivity. Methods Enzymol. 1996, 269:37-41.
69. Rouault T.A., Klausner R.D. The impact of oxidative stress on eukaryotic iron metabolism. EXS 1996, 77:183-197.
70. Kwon O.J., Lee S.M., Floyd R.A., Park J.W. Thiol-dependent metal-catalyzed oxidation of copper, zinc superoxide dismutase. Biochim. Biophys. Acta 1998, 1387:249-256.
71. Lee S.M., Huh T.L., Park J.W. Inactivation of NADP(+)-dependent isocitrate dehydrogenase by reactive oxygen species. Biochimie 2001, 83:1057-1065.
72. Macmillan-Crow L.A., Cruthirds D.L. Invited review: manganese superoxide dismutase in disease. Free Radic. Res. 2001, 34:325-336.
73. Alvarez B., Demicheli V., Duran R., Trujillo M., Cervenansky C., Freeman B.A., Radi R. Inactivation of human Cu,Zn superoxide dismutase by peroxynitrite and formation of histidinyl radical. Free Radic. Biol. Med. 2004, 37:813-822.
74. Kops G.J., Dansen T.B., Polderman P.E., Saarloos I., Wirtz K.W., Coffer P.J., Huang T.T., Bos J.L., Medema R.H., Burgering B.M. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 2002, 419:316-321.
75. Sarsour E.H., Agarwal M., Pandita T.K., Oberley L.W., Goswami P.C. Manganese superoxide dismutase protects the proliferative capacity of confluent normal human fibroblasts. J. Biol. Chem. 2005, 280:18033-18041.
76. Cho S.J., Park J.W., Kang J.S., Kim W.H., Juhnn Y.S., Lee J.S., Kim Y.H., Ko Y.S., Nam S.Y., Lee B.L. Nuclear factor-kappaB dependency of doxorubicin sensitivity in gastric cancer cells is determined by manganese superoxide dismutase expression. Cancer Sci. 2008, 99:1117-1124.
77. Bernard D., Quatannens B., Begue A., Vandenbunder B., Abbadie C. Antiproliferative and antiapoptotic effects of crel may occur within the same cells via the up-regulation of manganese superoxide dismutase. Cancer Res. 2001, 61:2656-2664.
78. Kim A., Oberley L.W., Oberley T.D. Induction of apoptosis by adenovirus-mediated manganese superoxide dismutase overexpression in SV-40-transformed human fibroblasts. Free Radic. Biol. Med. 2005, 39:1128-1141.
79. Oberley L.W., Oberley T.D., Buettner G.R. Cell division in normal and transformed cells: the possible role of superoxide and hydrogen peroxide. Med. Hypotheses 1981, 7:21-42.
80. Zou Y., Chen C.H., Fike J.R., Huang T.T. A new mouse model for temporal- and tissue-specific control of extracellular superoxide dismutase. Genesis 2009, 47:142-154.
81. Chen O.S., Schalinske K.L., Eisenstein R.S. Dietary iron intake modulates the activity of iron regulatory proteins and the abundance of ferritin and mitochondrial aconitase in rat liver. J. Nutr. 1997, 127:238-248.
82. Schalinske K.L., Blemings K.P., Steffen D.W., Chen O.S., Eisenstein R.S. Iron regulatory protein 1 is not required for the modulation of ferritin and transferrin receptor expression by iron in a murine pro-B lymphocyte cell line. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:10681-10686.